Curis Inc logo

Curis Inc

$ 0.80 +0.007 (+0.88%) 08:08 PM EST
P/E:
At Loss
P/B:
1.38
Market Cap:
$ 77.12M
Enterprise V:
$ -18.04M
Volume:
450.89K
Avg Vol (2M):
542.19K
Also Trade In:
Volume:
450.89K
Market Cap $:
77.12M
PE Ratio:
At Loss
Avg Vol (2-Month):
542.19K
Enterprise Value $:
-18.04M
PB Ratio:
1.38
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Name Current Vs Industry Vs History
Cash-To-Debt 23.49
Equity-to-Asset 0.45
Debt-to-Equity 0.08
Debt-to-EBITDA -0.08
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -12.77
Distress
Grey
Safe
Beneish M-Score -3.37
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.41
9-Day RSI 43.22
14-Day RSI 46.23
6-1 Month Momentum % 6.33
12-1 Month Momentum % -81.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.69
Quick Ratio 7.69
Cash Ratio 7.18
Days Sales Outstanding 94.84
Days Payable 5420.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -40.3

Financials (Next Earnings Date:2023-02-24 Est.)

CRIS's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:CRIS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10.41
EPS (TTM) ($) -0.64
Beta 2.66
Volatility % 84.71
14-Day RSI 46.23
14-Day ATR ($) 0.05554
20-Day SMA ($) 0.82616
12-1 Month Momentum % -81.95
52-Week Range ($) 0.68 - 5.27
Shares Outstanding (Mil) 96.4

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Curis Inc Filings

Document Form Filing Date
No Filing Data

Curis Inc Analysis

Share your research

Headlines

See More
No news.